Federal Register / Vol. 76, No. 48 / Friday, March 11, 2011 / Notices 13413 

EXHIBIT 1— ESTIMATED ANNUALIZED BURDEN HOURS

Interview type Maximum No. of 

respondents 

No. of responses 

per respondent 

Maximum hours 

per response 

Total burden 

hours 

Screening Questionnaire ......................................................... 120 1 3/60 6 

Needs Assessment .................................................................. 18 1 1.0 18 

Usability Testing ...................................................................... 18 1 1.5 27 

Discussion Groups ................................................................... 64 1 1.5 96 

Total .................................................................................. 120 na na 147 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Interview type Maximum No. of 

respondents 

Total burden 

hours 

Average hourly 

wage rate * Total cost burden 

Screening Questionnaire ......................................................... 120 6 $50.71 $304 

Needs Assessment .................................................................. 18 18 50.71 913 

Usability Testing ...................................................................... 18 27 50.71 1,369 

Discussion Groups ................................................................... 64 96 50.71 4,868 

Total .................................................................................. 120 147 NA 7,454 

* The hourly wage for the participants across the four data collections (screening questionnaire, needs assessment interview, usability testing 

interviews, and discussion group interviews) is based upon the mean of the average hourly wages for Social science research assistants (19– 

4061; $19.39 per hour); Postsecondary Health Specialties Teachers (25–1071; $53.88 per hour); Management analysts (13–1111; $40.70 per 

hour); Computer and Information Systems Managers (11–3021; $58.00 per hour); Family and General Practitioners Teachers (29–1060; $81.03 

per hour); Pharmacists (29–1051; $51.27 per hour). May 2009 National Occupational Employment and Wage Estimates, United States, U.S. Bureau of Labor Statistics Division of Occupational Employment Statistics http://www.bls.gov/oes/current/oes_nat.htm#29–0000. 

Estimated Annual Costs to the Federal 

Government 

The estimated total cost to the Federal 

Government for this project is 

$411,641.00 over a two-year period from 

September 8, 2010 to September 7, 

2012. The estimated average annual cost 

is $205,821. Exhibit 3 provides a 

breakdown of the estimated total and 

average annual costs by category. 

EXHIBIT 3—ESTIMATED TOTAL AND ANNUAL COST * TO THE FEDERAL GOVERNMENT

Cost component Total cost Annualized cost 

Project Management and Coordination Activities ....................................................................................... $58,140 $29,070 

Evaluation Plan and Protocol Development ................................................................................................ 44,908 22,454 

OMB Submission Package .......................................................................................................................... 12,362 6,181 

Conduct Evaluation ** .................................................................................................................................. 159,991 79,996 

Data Analysis, Report and Briefing ............................................................................................................. 118,081 59,041 

Documentation and 508 Compliance .......................................................................................................... 18,159 9,080 

Total ...................................................................................................................................................... 411,641 205,821 

* Costs are fully loaded including overhead, G&A and fees. 

** These activities include the data collections described in this submission. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ healthcare 

research and healthcare information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: March 2, 2011. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2011–5401 Filed 3–10–11; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP); Meeting 

Studies at the Animal-Human 

Interface of Influenza and Other 

Zoonotic Diseases in Vietnam, Funding 

Opportunity Announcement (FOA) 

IP11–005; The Incidence and Etiology of 

Influenza-Associated CommunityAcquired Pneumonia in Hospitalized 

Persons Study, FOA IP11–011; 

Spectrum of Respiratory Pathogens in 

Acute Respiratory Tract Infection 


srobinson on DSKHWCL6B1PROD with NOTICES
13414 Federal Register / Vol. 76, No. 48 / Friday, March 11, 2011 / Notices 

Among Children and Adults in India, 

FOA IP11–012; Influenza Vaccine 

Efficacy in Tropical and Developing 

Countries, FOA IP11–013; and Influenza 

and Other Respiratory Diseases in 

Southern Hemisphere, FOA IP11–014; 

initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 8 a.m.–5 p. m., May 12, 

2011 (Closed). 

Place: Sheraton Gateway Hotel Atlanta 

Airport, 1900 Sullivan Road, Atlanta, Georgia 

30337, Telephone: (770) 997–1100. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Studies at the Animal-Human 

Interface of Influenza and Other Zoonotic 

Diseases in Vietnam, FOA IP11–005; The 

Incidence and Etiology of InfluenzaAssociated Community-Acquired Pneumonia 

in Hospitalized Persons Study, FOA IP11– 

011; Spectrum of Respiratory Pathogens in 

Acute Respiratory Tract Infection Among 

Children and Adults in India, FOA IP11–012; 

Influenza Vaccine Efficacy in Tropical and 

Developing Countries, FOA IP11–013; and 

Influenza and Other Respiratory Diseases in 

Southern Hemisphere, FOA IP11–014, initial 

review.’’ 

Contact Person for More Information: 

Gregory Anderson, M.S., M.P.H., Scientific 

Review Officer, CDC, 1600 Clifton Road, NE., 

Mailstop E60, Atlanta, Georgia 30333, 

Telephone: (404) 498–2293. The Director, 

Management Analysis and Services Office, 

has been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 7, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–5626 Filed 3–10–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Continuation of the 

National Mesothelioma Virtual Bank for 

Translational Research, Program 

Announcement PAR 11–002, Initial 

Review 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 2 p.m.–4 p.m., April 5, 

2011 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Continuation of the National 

Mesothelioma Virtual Bank for Translational 

Research, PAR 11–002.’’ 

Contact Person for More Information: M. 

Chris Langub, Ph.D., Scientific Review 

Officer, CDC, 1600 Clifton Road, NE., 

Mailstop E74, Atlanta, Georgia 30333, 

Telephone: (404) 498–2543. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 3, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–5630 Filed 3–10–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Pilot 

Longitudinal Data Collection To Inform 

Public Health—Fragile X Syndrome, 

DD11–007, Initial Review 

Notice of Cancellation: This notice 

was published in the Federal Register 

on December 17, 2010, Volume 75, 

Number 242, page 78997. 

This SEP previously scheduled to 

convene on April 15, 2011, is cancelled 

in its entirety. 

Contact Person for More Information: 

Donald Blackman, Ph.D., Scientific 

Review Officer, CDC, National Center 

for Chronic Disease Prevention and 

Health Promotion, Office of the Director, 

Extramural Research Program Office, 

4770 Buford Highway, NE., Mailstop K– 

92, Atlanta, Georgia 30341, Telephone: 

(770) 488–3023, E-mail: DBY7@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 4, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–5628 Filed 3–10–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Evaluation of 

the Impact of Work or School 

Exclusion Criteria on the Spread of 

Influenza and Influenza-Like-Illness 

(U01), Funding Opportunity Number 

(FOA) CK11–007, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 8 a.m.–5 p.m., May 2, 2011 

(Closed). 

Place: Sheraton Gateway Hotel Atlanta 

Airport, 1900 Sullivan Road, Atlanta, Georgia 

30337, Telephone: (770) 997–1100. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Evaluation of the Impact of 

Work or School Exclusion Criteria on the 

Spread of Influenza and Influenza-like-Illness 

(U01), FOA CK11–007.’’ 

Contact Person for More Information: Dr. 

Amy Yang, Scientific Review Officer, CDC, 

1600 Clifton Road, NE., Mailstop E60, 


srobinson on DSKHWCL6B1PROD with NOTICES